Lab21 acquires Axis Shield's Plasmatec unit

05/21/2009 | Reuters

Axis Shield, which makes in vitro diagnostics tests, said its Plasmatec Laboratory Products division was acquired by the Cambridge, U.K.-based firm Lab21 for an undisclosed amount. "This divestment reflects our increasing focus on high-margin diagnostic technologies, markets and our investment in state-of-the-art testing at point of care," said Ian Gilham, CEO of Axis Shield.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY